Work

Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa

Year: 2024

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2024.01.066

Authors: Azwidihwi Takalani, Michelle Robinson, Phumeza Jonas, Annie Bodenstein, Vuyelo Sambo, Barry Jacobson, Vernon Louw, Jessica Opie, Jonny Peter, Pradeep Rowji, Ishen Seocharan, Tarylee Reddy, Nonhlanhla Yende-Zuma, Kentse Khutho, Ian Sanne, Linda-Gail Bekker, Glenda Gray, Nigel Garrett, Ameena Goga

Institutions: University of the Witwatersrand, Chris Hani Baragwanath Hospital, Right to Care, National Health Laboratory Service, University of Cape Town, Groote Schuur Hospital, Milpark Hospital, South African Medical Research Council, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, University of Pretoria

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Allergy and Infectious Diseases

Awards: Units for HIV/AIDS Clinical Trials Networks, Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication

OpenAlex ID: W4391234932

FWCI: 0.601

Cites: 18

Cited by: 2

Related to: 10